openPR Logo
Press release

Endovascular Devices Market Future of Intervention Advancements Drive Innovation 2024-2031

05-26-2024 07:32 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: InsightAce Analytic Pvt.Ltd

/ PR Agency: InsightAce Analytic Pvt.Ltd
Endovascular Devices Market Future of Intervention

Endovascular Treatment Devices Market

Endovascular Treatment Devices Market to reach over USD 5.77 billion by the year 2030;

Market Synopsis-

The newly published report titled "Global Endovascular Treatment Devices Market (Product (percutaneous endovascular aneurysm repair (EVAR), fenestrated EVAR, aortic stents biodegradable stents, self-expanding nitinol stents, thoracic aortic aneurysm grafts and other devices), Procedure (Ballon Angioplasty, Angioplasty With Stent Replacement, Drug-Eluting Stents Renal

Artery Angioplasty and Stenting Carotid Artery, Thrombosis, Renal Artery Angioplasty and Stenting, Transfemoral Carotid Artery Revascularization, Intravascular Brachytherapy, Carotid Artery Stenting), Application (pulmonary, vascular, cardiology surgery, neurology and radiology))- By Trends, Industry Competition Analysis, Covid-19 Analysis, Revenue (US$ Billions) and Forecast Till 2030."

of InsightAce Analytic Pvt. Ltd. features detailed industry analysis and an extensive study on the market, exploring its significant factors.
The global Endovascular Treatment Devices market is estimated to reach over USD 5.77 billion by 2030, exhibiting a CAGR of 8.52% during the forecast period.

Get a free sample copy of the report: https://www.insightaceanalytic.com/request-sample/1364

Advanced minimally invasive procedures like endovascular surgery are utilized to treat blood artery-related medical disorders like aneurysms and bulging or "ballooning" blood vessels. A body incision is made at the start of the treatment to access the blood vessels. Next, a flexible plastic tube, stent, or catheter is placed into the damaged blood artery to allow the patient's bloodstream to administer or withdraw medication.

Endovascular therapeutic devices are used in chemotherapy, blood transfusions, intravenous antibiotic therapy, and long-term intravenous nutrition. The market for endovascular treatment devices is expected to grow during the forecast period due to factors like an ageing population, a rise in the prevalence of cardiovascular diseases, technologically advanced endovascular products, and increased spending on research and development by market players.

The high expense of endovascular operations, a lack of understanding in developing nations, and a shortage of qualified surgeons to carry out the procedures are impeding market progress. Due to innovative product introductions and increased healthcare spending, endovascular treatment devices have increased, driving research and development.

List of Prominent Players in the Endovascular Treatment Devices Market:
Medtronic
Lombord Medical
Penumbra, Inc.
Terumo Corporation
Cardinal Health
Endospan
Geting AB
Bosten Scientific Corporation
Inspire MD
Japan Lifeline Co., Ltd.

Market Dynamics:

Drivers-
In the upcoming years, market growth will also be fueled by the high prevalence of abdominal aortic aneurysms, which are more common in men, and a potential rise in demand for minimally invasive techniques like endovascular surgery. The majority of abdominal aortic aneurysms (AAA), which mainly afflict men, range from 4% to 8%, according to screening studies.

Due to the growing global geriatric population, AAA prevalence is high in the ageing population and could become substantial in the future. The market for endovascular treatment devices will proliferate due to rapid technological advancement and considerable improvements in minimally invasive surgery.

Challenges:
Some of the main obstacles in the global market for endovascular treatment devices are anticipated to include the high cost associated with using new endovascular therapy devices, a lack of awareness in economically underdeveloped countries, and the US's strict tax regulations on medical products.

Regional Trends:
The North America Endovascular Treatment Devices market is expected to register a significant market share in revenue and is projected to grow at a high CAGR shortly. The market has grown due to an increase in surgical operations and medical professionals' desire for these devices, which has led big businesses to concentrate on developing cutting-edge medical devices in these countries.

The region's endovascular therapy devices market will grow due to the obesity and diet epidemics, as well as the development of new products due to prominent manufacturers. Besides, Asia Pacific had a substantial share in the endovascular treatment devices market. Increased medical advancements have contributed to the endovascular treatment devices market revenue growth in this area, leading to continuing industry expansion. Increased R&D efforts and medical advances made by significant participants in the region's nations can also be credited with growth.

Inquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1364

Recent Developments:
In November 2021, Endospan released 30-day and 1-year safety and performance results for its off-the-shelf endovascular Nexus graft devices, designed to treat thoracic aortic lesions involving the aortic arch.
In September 2021, Boston Scientific Corporation agreed to buy Devoro Medical, the developer of the WOLF Thrombectomy Platform, to expand its interventional techniques for thromboembolism, including the EkoSonic Endovascular System.
Segmentation of Endovascular Treatment Devices Market-

By Product-
• Percutaneous Endovascular Aneurysm Repair (EVAR)
• Fenestrated EVAR
• Aortic Stents Biodegradable Stents
• Self-Expanding Nitinol Stents
• ThoracicAortic Aneurysm Grafts
• Other Devices

By Procedure-
• Ballon Angioplasty
• Angioplasty With Stent Replacement
• Drug-Eluting Stents Renal Artery Angioplasty and Stenting Carotid Artery
• Thrombosis
• Renal Artery Angioplasty and Stenting
• Transfemoral Carotid Artery Revascularization
• Intravascular Brachytherapy
• Carotid Artery Stenting

By Application-
• Pulmonary
• Vascular
• Cardiology Surgery
• Neurology
• Radiology

By Region-
North America-
• The US
• Canada
• Mexico

Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific

Latin America-
• Brazil
• Argentina
• Rest of Latin America

Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

For Customization: https://www.insightaceanalytic.com/customisation/1364

Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.
Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Endovascular Devices Market Future of Intervention Advancements Drive Innovation 2024-2031 here

News-ID: 3512807 • Views:

More Releases from InsightAce Analytic Pvt.Ltd

Ultrasound Imaging Software Market Seeing Clearly, Growing Steadily A Brighter Future in Medical Diagnosis
Ultrasound Imaging Software Market Seeing Clearly, Growing Steadily A Brighter F …
Ultrasound Imaging Software Market Assessment worth $ 1.98 Billion by 2030 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Ultrasound Imaging Software Market- by Service Types (Integrated, Standalone, and Next Generation/AI-based Software), Application (Radiology, OB/GYN, Urology, Cardiology, and Others (Orthopedic, etc.)), End-Users (Hospitals, Speciality Clinics, and Others (ASCs, Research Institutes, etc.)), Trends, Industry Competition Analysis, Revenue and Forecast
Sustainable Aquaculture Nutrition is Revolutionizing Seafood Feeding the Future From Feed to Fork
Sustainable Aquaculture Nutrition is Revolutionizing Seafood Feeding the Future …
Sustainable Feed & Nutrition for Aquaculture Market Assessment worth $ 13.1 Billion by 2030 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Sustainable Feed & Nutrition for Aquaculture Market- by Ingredients (Amino Acids, Phosphates, Vitamins, Acidifiers, Carotenoids, Enzymes, Mycotoxin Detoxifiers, Antibiotics, Minerals, Antioxidants, Non-protein Nitrogen, Phytogenics, Probiotics, and Other Ingredients), Feed (Algae, Insect, and Single-Cell Protein), Trends, Industry
Ultra-Low Temperature Freezer Market Securing the Future of Science Growth Prospects in the Ultra-Low Temperature Freezer Market
Ultra-Low Temperature Freezer Market Securing the Future of Science Growth Prosp …
Ultra-Low Temperature Freezers Market Assessment worth $ 904.08 Million by 2030 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Ultra-Low Temperature Freezers Market- by Types (Chest Freezers, Upright Freezers, and Other Types), Technology (Automated and Semi-automated), Applications (Blood and blood products, Organs, Pharmaceuticals, Forensic and Genomic Research, and Other Applications), Trends, Industry Competition Analysis, Revenue and Forecast To
TROP2 Targeted Therapy Market Targeting the Future of Cancer Treatment Unlocking New Possibilities
TROP2 Targeted Therapy Market Targeting the Future of Cancer Treatment Unlocking …
Global TROP2 (Trophoblast Cell-surface Antigen 2) Targeted Cancer Therapy Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global TROP2 (Trophoblast Cell-surface Antigen 2) Targeted Cancer Therapy Market- (By Application (Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Pancreatic Cancer, and Others)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To

All 5 Releases


More Releases for Endovascular

Aortic Aneurysm Market Competitive Dynamics | Endovascular Technology Corp, Cryo …
Portrayed as a silent killer by medical experts, instances of (abdominal) aortic aneurysm are underpinned by hypertension, atherosclerosis, infection of aorta, and diseased aortic blood vessels. Besides smoking and tobacco consumption, hyperlipidemia, aging and a strong family history of CVDs and/or hyperlipidemia are cited as the key risk factors associated with aortic aneurysm condition, raising the demand for treatment of aortic aneurysm. Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=4716 Competition
Endovascular Therapy Devices Market Dynamics, Forecast, Analysis and Supply Dema …
Endovascular therapy Devices: Market Insights A procedure involving endovascular therapy devices are used to insert a flexible, sterile plastic tube, stents or a catheter into a blood vessel to allow blood to be withdrawn from or medication to be delivered to a patient’s bloodstream over a period of time. These endovascular therapy devices can be used either for intravenous antibiotic treatment, chemotherapy, long-term intravenous feeding and blood transfusions. The market is
Endovascular Aneurysm Repair (EVAR) Market - Global Industry Insights, Trends, O …
Aortic aneurysm is a medical condition, in which aorta, gets enlarged. Abdominal and Thoracic are two categories of aortic aneurysm. These conditions can lead to abdominal pain, low blood pressure, loss of consciousness or even death. Endovascular aneurysm repair (EVAR) is a minimally invasive surgical method to treat abdominal and thoracic aortic aneurysm. It is an alternative to open surgery for abdominal aortic aneurysm (AAA), which makes it relatively safe
Endovascular Aneurysm Repair (EVAR) Market - Global Industry Insights, 2026
Aortic aneurysm is a medical condition, in which aorta, gets enlarged. Abdominal and Thoracic are two categories of aortic aneurysm. These conditions can lead to abdominal pain, low blood pressure, loss of consciousness or even death. Endovascular aneurysm repair (EVAR) is a minimally invasive surgical method to treat abdominal and thoracic aortic aneurysm. It is an alternative to open surgery for abdominal aortic aneurysm (AAA), which makes it relatively safe
Endovascular Aneurysm Repair (EVAR) Market | Global Outlook
Aortic aneurysm is a medical condition, in which aorta, gets enlarged. Abdominal and Thoracic are two categories of aortic aneurysm. These conditions can lead to abdominal pain, low blood pressure, loss of consciousness or even death. Endovascular aneurysm repair (EVAR) is a minimally invasive surgical method to treat abdominal and thoracic aortic aneurysm. It is an alternative to open surgery for abdominal aortic aneurysm (AAA), which makes it relatively safe
Major Growth Factors of the Global Endovascular Aneurysm Repair Market
North America is expected to hold a dominant position in global endovascular aneurysm repair (EVAR) market over the forecast period North America accounted for the largest share in the global endovascular aneurysm market in 2016, owing to increasing prevalence of aneurysms and rising geriatric population, which is more prone to this condition. According to the New England Journal of Medicine, 2016, 278,921 patients underwent repair of abdominal aortic aneurysm in the